Atlas Trials

Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors

Clinical trial NCT00960440 · COMPLETED

Trial details

NCT number
NCT00960440
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Arthritis, Rheumatoid
Start date
2009-10-01
Primary completion
2011-03-01
Enrollment
399

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.